Assessment of the effectiveness of BNT162b2 vaccine against Omicron in children 5 to 11 years of age
Latest Information Update: 07 Jul 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 07 Jul 2022 Status changed from not stated to completed.
- 05 Jul 2022 New trial record
- 29 Jun 2022 Results published in the New England Journal of Medicine